Description: In-depth discussion about HIV and AIDS: [1] mortality-study results, [2] risk-classification challenges, including regulatory issues, [3] mortality-projection methods, [4] significant pricing and valuation – STAT and GAAP – information, and [5] overall industry implications. From the 1988 Record of Society of Actuaries, Vol. 14, No. 4A.

Description: This session at the SOA 1990 San Francisco Spring Meeting focuses on AIDS including an update on the epidemic and discussion about the actuarial implication of four case studies.

Description: Discusses mortality improvements over the last 20 years, the extent to which premiums on nonparticipating policies reflect the changes in mortality experience, the proposed new valuation table, should valuation tables be split by gender, and extra mortality on substandard lives at very long durations.

Description: Panelists discuss the new Guideline XXX for reserves for term products, including re-entry term, and in the context of HIV/AIDS. Session 5 of the 1991 Valuation Actuary Symposium.

Description: From the 1985 Valuation Actuary Symposium. A discussion of the principles that should be part of a life insurance valuation. Also discussion of emerging actuarial professional standards of practice and regulatory requirements with respect to methodology for assessing reserve adequacy.

Description: The valuation manual is a living document that continues to evolve. As more companies adopt Principle-Based Reserving (PBR) and file PBR Actuarial Reports, regulators have observed gaps and inconsistencies across the industry. As a result, PBR reporting requirements (VM-31) have expanded significantly in 2020 and still continue to evolve. This session will provide attendees with everything they need to fill out their PBR reports for both Life business and Variable Annuity business. We will dig into the new changes effective for 2020 reporting and approved changes for 2021, and compare and contrast the Life and VA requirements to help companies identify areas that can be leveraged between the two. In addition, we will share insights from regulators, consultants, and company actuaries on what to include or exclude in your report.

Description: This is a discussion about the business effects of adoption of the 1958 CSO mortality table, possible reasons for the declining trend in individual life insurance sales, and effects of NY limitations on commissions and developments in agency earnings that could lead to modifications in the agency system.

Description: Panelists provide background and updates on a number of statutory issues relating to life and annuity products, including statutory codification implementation, Actuarial Guideline MMMM, Actuarial Guideline AXXX and implications of the movement to the 2001 CSO table. Changes to federal reporting requirements, through the Sarbanes-Oxley Act, are briefly discussed relative to the recent accounting problems in the news. From the 2002 Record of Society of Actuaries, Volume 28, No. 3. Session 78OF of the Boston Annual Meeting.

Description: Presented at September 1995 Valuation Actuary Symposium. This presentation will cover differences in Regulation XXX and Regulation 147, possible new XXX designs, and consumer reaction to NAIC's adoption of XXX.

Description: Regulators observed a wide range of practice from early adopters of PBR in regard to the treatment of non-guaranteed reinsurance and adopted a formulaic solution on an interim basis for the 2020 Valuation Manual. A field test, supplemented with additional analysis performed using a model-office approach with representative models, is being performed over the first half of 2020 to inform regulators as they select a longer-term solution. This session will provide an update on this important issue as well as perspectives on how the resolution of this issue was approached and lessons learned for the future from those intimately involved in this work.